文献速递造血干细胞移植与细胞治疗

儿童异基因造血干细胞移植后巨细胞病毒感染与供者HLA型别识别巨细胞病毒抗原肽亲和力差异的相关性

[The correlation between post-allo-HSCT CMV infection and the difference affinity of donor HLA-type recognition of CMV antigen peptide in children].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2021-01-01

该研究回顾性分析武汉儿童医院146例异基因造血干细胞移植患儿移植后6个月内巨细胞病毒感染情况,探讨供者HLA型别识别巨细胞病毒抗原肽亲和力与移植后感染的相关性。结果显示,供者HLA型别与PP65单独高亲和力82例中移植后感染34例(41.46%),而伴有IE-1高亲和力HLA位点供者移植后感染发生率更低(22.81%对41.46%,P=0.029)。

要点

  • 146例患儿中,供者HLA型别与PP65单独高亲和力82例(56.16%),其中移植后发生CMV感染34例(41.46%)。
  • 与仅携带PP65高亲和力等位基因组比较,伴有IE-1高亲和力HLA位点供者移植后CMV感染发生率更低(22.81%对41.46%,P=0.029)。
  • CMV PP65和IE-1高亲和力型别HLA类型覆盖约99.8%的供者。

核心结论

  • CMV PP65和IE-1高亲和力型别HLA类型覆盖约99.8%的供者。
  • 选择CMV抗原肽IE-1高亲和力型别HLA供者或可降低儿童血液病患者allo-HSCT后CMV感染风险。

研究设计与样本

  • 回顾性分析武汉儿童医院血液肿瘤科146例allo-HSCT患儿移植后6个月内发生CMV再激活、CMV感染、CMV组织器官病的数据。

主要发现

  • 146例患儿中HLA型别与PP65单独高亲和力82例(56.16%),移植后发生CMV感染34例(41.46%)。
  • IE-1高亲和力型5例,移植后感染0例;无明确亲和力多肽2例,感染0例。
  • PP65+IE-1高亲和力型52例,移植后感染13例(25.00%);与PP65和PP50共同高亲和力型5例,移植后感染3例;未遇到仅与PP50高亲和力HLA供者。
  • 与仅携带PP65高亲和力等位基因组比较,伴有IE-1高亲和力HLA位点供者移植后表现出更低的CMV感染发生率(22.81%对41.46%,P=0.029)。

临床怎么用

  • 作者认为,选择CMV抗原肽IE-1高亲和力型别HLA供者或可降低儿童血液病患者allo-HSCT后CMV感染风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the correlation between the affinity while donor's HLA type recognizing different cytomegalovirus (CMV) antigen peptide and the occurrence of CMV infection after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in children. Methods: To investigate the relationship between CMV reactivation, CMV infection or CMV related tissue/organ diseases and the different HLA-type recognition antigen peptide of the donors, we retrospectively analyzed the clinical data of 146 children with CMV infection for 6 months since from the time they underwent transplantation in Wuhan Children's Hospital. Results: Among 146 patients, the HLA type of 82 (56.16%) cases had high affinity with PP65 alone, and 34 cases of CMV infection occurred after transplantation (41.46%) . None of 5 cases that had a high affinity with IE-1 alone got CMV infection. None of 2 cases with no clear high-affinity peptide had CMV infection. Three of 5 cases that had a high affinity with PP65 and PP50 had CMV infection. Thirteen of 52 cases that had a high affinity with PP65 and IE-1 had CMV infection (25.00%) . HLA with exclusive PP50 high affinity was not encountered. Donors with a high-affinity HLA locus associated with IE-1 showed a lower incidence of CMV infection after HSCT compared to those carrying only the PP65 high-affinity allele (22.81% vs 41.46%, P=0.029) . Conclusion: HLA type with PP65 and IE-1 high-affinity covers approximately 99.8% of the donors. Stem cells generated from HLA donors with high affinity with the CMV antigen peptide IE-1 can reduce the risk of post-transplantation CMV-activated infection in children. 目的: 探索儿童异基因造血干细胞移植(allo-HSCT)后供者HLA型别识别不同巨细胞病毒(CMV)抗原肽亲和力与发生CMV感染的相关性。 方法: 回顾性分析武汉儿童医院血液肿瘤科146例allo-HSCT患儿移植后6个月内发生CMV再激活、CMV感染、CMV组织器官病的数据,分析其与供者HLA型别识别CMV抗原肽差异的相关性。 结果: 纳入研究的146例移植后患儿中HLA型别与PP65单独高亲和力82例(56.16%),移植后发生CMV感染34例(41.46%);IE-1高亲和力型5例,移植后感染0例;无明确亲和力多肽2例,感染0例;PP65+IE-1高亲和力型52例,移植后感染13例(25.00%);与PP65和PP50共同高亲和力型5例,移植后感染3例;未遇到仅与PP50高亲和力HLA供者。与仅携带PP65高亲和力等位基因组比较,伴有IE-1高亲和力HLA位点供者移植后表现出更低的CMV感染发生率(22.81%对41.46%,P=0.029)。 结论: CMV PP65和IE-1高亲和力型别HLA类型覆盖约99.8%的供者,选择CMV抗原肽IE-1高亲和力型别HLA供者或可降低儿童血液病患者allo-HSCT后CMV感染风险。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yang L, Wang Z, Wu S, et al. [The correlation between post-allo-HSCT CMV infection and the difference affinity of donor HLA-type recognition of CMV antigen peptide in children]. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34753231. doi:10.3760/cma.j.issn.0253-2727.2021.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。